Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer |
| |
| Authors: | G P Stathopoulos D Antoniou J Dimitroulis J Stathopoulos K Marosis P Michalopoulou |
| |
| Affiliation: | (1) First Oncology Clinic, Errikos Dunant Hospital, Semitelou 2A, 115 28 Athens, Greece;(2) Hospital for Thoracic Disorders, Athens, Greece |
| |
| Abstract: | Purpose Liposomal cisplatin was developed to reduce the systemic toxicity of cisplatin, particularly the nephrotoxicity, and it has
been used in combination with other agents in pancreatic and head and neck cancers and non-small-cell lung cancer (NSCLC).
Our objective was to compare the effectiveness of lipoplatin combined with paclitaxel versus cisplatin with paclitaxel in
advanced non-squamous NSCLC. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
